Novo Nordisk prepares to launch muscle mass preservation drug
The Danish pharmaceutical giant thereby follows on the heels of competitor Eli Lilly.
by marketwire
Novo Nordisk is also on the way with a new treatment that will ensure that overweight people can be treated for weight loss and not risk losing muscle mass at the same time, executive vice president for Development Martin Holst Lange announced on Thursday at a teleconference for analysts.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
